More from Nature

In addition to the editorial on impact factors (see previous posting), the latest Nature also contains:

An article on a funding crisis for life sciences databases (databases of genomic data, and so on)

A piece about BiDiL, a drug for congestive heart failure which will be sold with a label designating African Americans as the target population.

The latest in the PubChem vs. CAS debate (the American Chemical Society has had concerns over PubChem, a free database, in the light of the fact that it produces a fee based service that it says does the same thing) - scroll down to the fourth news item in this link

A research news item on a paper in the Journal of Experimental Medicine which looks at the involvement of phages in making Neisseria meningitidis infectious. The actual abstract is here.